---
$id: https://graph.org.ai/products/commodity/51162106
$type: Product
source: UNSPSC
code: "51162106"
title: "Ethambutol/isoniazid/pyrazinamide/rifampicin"
class: "51162100"
classTitle: "Combination antituberculars"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ethambutol/isoniazid/pyrazinamide/rifampicin

**UNSPSC Code**: 51162106
**Class**: [Combination antituberculars](Combination antituberculars.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

Definition: This classification is for a combination medication for TB treatment. The first component, ETHAMBUTOL, has US FDA Unique Ingredient Identifier of 8G167061QZ. ETHAMBUTOL is an International Non-Proprietary Name or INN. The second component, ISONIAZID, has US FDA Unique Ingredient Identifier of V83O1VOZ8L. ISONIAZID is an International Non-Proprietary Name or INN. The third component, PYRAZINAMIDE, has US FDA Unique Ingredient Identifier of 2KNI5N06TI. PYRAZINAMIDE is an International Non-Proprietary Name or INN. The fourth component, RIFAMPICIN, has US FDA Unique Ingredient Identifier of VJT6J7R4TR. RIFAMPICIN is an International Non-Proprietary Name or INN.

